Enhanced HLA-DR expression on T-lymphocytes from patients in early stages of non-surgical sepsis

Med Clin (Barc). 2019 May 3;152(9):346-349. doi: 10.1016/j.medcli.2018.07.007. Epub 2018 Sep 25.
[Article in English, Spanish]

Abstract

Introduction: Early detection of sepsis is a critical step to improve patient's survival and cellular markers effective diagnosis tools. The aim of this work was to evaluate HLA-DR expression on peripheral T-lymphocytes (CD3+), a marker associate to T-cell activation, as an early sepsis detection tool.

Patients and methods: A cross-sectional study was conducted in twenty-six patients with confirmed sepsis by blood culture, eighteen healthy individuals and four patients with systemic inflammatory response syndrome. The analysis of the HLA-DR expression was carried by flow cytometry.

Results: The patients with confirmed sepsis had significantly higher percentage of CD3+/HLA-DR+ lymphocytes compared with both, patients with SIRS (20.37±9.42 vs. 8.7±2.9; p<0.005) and healthy individuals (20.37±9.42 vs. 6.58±3.89; p<0.005). Moreover, the average amount of HLA-DR expressed was higher when caused by gram-positive than by gram-negative bacterias (216.61±131.35 vs. 135.05±31.82; p=0.041). A ROC curve analysis showed the utility of HLA-DR expression on T-cells to identify patients with sepsis.

Discussion: Our results suggest that surface expression of HLA-DR on T-lymphocytes could be an early marker for the presence of sepsis in non-surgical septic patients.

Keywords: HLA-DR; Linfocitos T; Sepsis; T-lymphocytes.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • CD3 Complex / blood
  • Case-Control Studies
  • Cross-Sectional Studies
  • Early Diagnosis
  • Female
  • Flow Cytometry
  • HLA-DR Antigens / blood*
  • Humans
  • Male
  • Middle Aged
  • ROC Curve
  • Sepsis / blood
  • Sepsis / diagnosis*
  • T-Lymphocytes / metabolism*

Substances

  • Biomarkers
  • CD3 Complex
  • HLA-DR Antigens